Leukocyte counts in cerebrospinal fluid and blood following firategrast treatment in subjects with relapsing forms of multiple sclerosis. [electronic resource]
Producer: 20140117Description: 1032-42 p. digitalISSN:- 1468-1331
- Adult
- Anti-Inflammatory Agents -- adverse effects
- Antibodies, Monoclonal, Humanized -- adverse effects
- Female
- Humans
- Integrin alpha4beta1 -- antagonists & inhibitors
- Integrins -- antagonists & inhibitors
- Leukocyte Count
- Lymphocyte Count
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- blood
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.